{"id":349,"date":"2022-06-29T17:03:52","date_gmt":"2022-06-29T15:03:52","guid":{"rendered":"https:\/\/neuropediatoolbox.wordpress.com\/?p=349"},"modified":"2022-09-29T12:25:52","modified_gmt":"2022-09-29T12:25:52","slug":"uso-compasivo-y-medicacion-extranjera","status":"publish","type":"post","link":"https:\/\/neuropediatoolkit.org\/fr\/uso-compasivo-y-medicacion-extranjera\/","title":{"rendered":"Usage compassionnel, m\u00e9dicaments \u00e9trangers et utilisation de m\u00e9dicaments hors AMM (off AMM)."},"content":{"rendered":"<p class=\"wp-block-paragraph\">Le lien AEMS explique les trois notions, ainsi que dans quels cas il est n\u00e9cessaire de demander une autorisation et par quels moyens cela doit \u00eatre fait. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Exemples courants en neurologie p\u00e9diatrique\u00a0: <\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>\u00c9thosuximide en sirop (non commercialis\u00e9 en Espagne), disponible dans les pharmacies hospitali\u00e8res comme m\u00e9dicament \u00e9tranger. <\/li><li>Cannabidiol dans le syndrome de Rett (pour les patients sous traitement apr\u00e8s inclusion dans un essai clinique et ach\u00e8vement de l'essai, Identifiant ClinicalTrials.gov : NCT04252586). Utilisation compassionnelle. <\/li><li><\/li><\/ul>\n\n\n\n<figure class=\"wp-block-embed is-type-wp-embed is-provider-agencia-espanola-de-medicamentos-y-productos-sanitarios wp-block-embed-agencia-espanola-de-medicamentos-y-productos-sanitarios\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"wp-embedded-content\" data-secret=\"z16RkUnlVl\"><a href=\"https:\/\/www.aemps.gob.es\/medicamentos-de-uso-humano\/acceso-a-medicamentos-en-situaciones-especiales\/instrucctramitacion\/\">Instructions pour le traitement des demandes<\/a><\/blockquote><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"\u00abInstructions pour le traitement des demandes\u00bb \u2014 Agence espagnole des m\u00e9dicaments et des produits de sant\u00e9\" src=\"https:\/\/www.aemps.gob.es\/medicamentos-de-uso-humano\/acceso-a-medicamentos-en-situaciones-especiales\/instrucctramitacion\/embed\/#?secret=6HMo3qHvIC#?secret=z16RkUnlVl\" data-secret=\"z16RkUnlVl\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe>\n<\/div><\/figure>","protected":false},"excerpt":{"rendered":"<p>Le lien AEMS explique les trois notions, ainsi que dans quels cas il est n\u00e9cessaire de demander une autorisation et par quels moyens cela doit \u00eatre fait. Exemples courants en neurologie p\u00e9diatrique : \u00c9thosuximide en sirop (non commercialis\u00e9 en Espagne), disponible dans les pharmacies hospitali\u00e8res comme m\u00e9dicament \u00e9tranger. Cannabidiol dans le syndrome de Rett (pour les patients sous traitement\u2026 <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/neuropediatoolkit.org\/fr\/uso-compasivo-y-medicacion-extranjera\/\" class=\"more-link\">Continuer la lecture<span class=\"screen-reader-text\"> \u00abUsage compassionnel, m\u00e9dicaments \u00e9trangers et usage de m\u00e9dicaments hors AMM (off label).\u00bb<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":2657,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[24],"tags":[],"class_list":["post-349","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-farmacos","entry"],"_links":{"self":[{"href":"https:\/\/neuropediatoolkit.org\/fr\/wp-json\/wp\/v2\/posts\/349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neuropediatoolkit.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neuropediatoolkit.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/fr\/wp-json\/wp\/v2\/comments?post=349"}],"version-history":[{"count":0,"href":"https:\/\/neuropediatoolkit.org\/fr\/wp-json\/wp\/v2\/posts\/349\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/fr\/wp-json\/wp\/v2\/media\/2657"}],"wp:attachment":[{"href":"https:\/\/neuropediatoolkit.org\/fr\/wp-json\/wp\/v2\/media?parent=349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/fr\/wp-json\/wp\/v2\/categories?post=349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neuropediatoolkit.org\/fr\/wp-json\/wp\/v2\/tags?post=349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}